eczema
MHRA approves new oral treatment for moderate-to-severe plaque psoriasis
Plaque psoriasis is an inflammatory condition that causes red, scaly and often itchy or painful patches of skin
New MHRA research published on needle-free Strep A vaccine
There is currently no licensed vaccine for Strep A, despite it causing hundreds of millions of infections globally
First-ever World Chronic Hand Eczema Day launches on 5 October
The new global awareness initiative calls for greater recognition, understanding and support for people living with chronic hand eczema
MHRA approves Pharma Mar’s lurbinectedin for extensive-stage small cell lung cancer
The treatment is for adults in combination with atezolizumab
Moderna’s updated COVID-19 mRNA vaccine approved by MHRA
The updated vaccine will be available to eligible groups as part of the 2026/27 NHS vaccination programme
LEO Pharma elects Henriette Mersebach to the Board of Directors
Mersebach previously held senior leadership positions at ALK-Abelló and Novo Nordisk
LEO Pharma acquires rights for dersimelagon from Tanabe Pharma
The company will pay $435m in up front and near-term milestone payments
Eli Lilly’s Foundayo authorised by UK MHRA for weight loss and type 2 diabetes
The UK is the first country in Europe to authorise the oral medication
LEO Pharma and Allergy UK launch ‘Don’t Ignore’ chronic hand eczema campaign
The campaign aims to improve awareness and understanding of the condition
LEO Pharma to acquire Replay gene therapy platform
The acquisition will advance innovation for patients with rare skin diseases
MHRA authorises Biogen’s higher-dose Spinraza for SMA treatment
SMA is a rare genetic neuromuscular condition affecting around 1,600 people in the UK
UK clinical trial regs are changing — here’s what’s happening
Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.